Loading...
New

Aerosol Delivery Devices Market by Product (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Non-Respiratory Diseases), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and E-commerce): Global Opportunity Analysis and Industry Forecast, 2020–2027

A06788
Pages: 277
Aug 2020 | 644 Views
 
Author(s) : Sayali Shinde, Sushant Terdale , Onkar Sumant
Tables: 139
Charts: 59
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Aerosol Delivery Devices Market

Request Now !

The global aerosol delivery devices market was valued at $31,464 million in 2019, and is projected to reach $46,729 million by 2027, registering a CAGR of 4.9% from 2020 to 2027.

Aerosol delivery devices are used as rescue therapy or permanent treatment for respiratory diseases and non-respiratory diseases. It is the most advanced mode of drug administration treatment in which a drug is directly delivered to lungs to offer a systemic effect. Aerosol delivery devices are frequently used in treatment of asthma and COPD, which includes dry powder inhalers, metered dose inhalers, and nebulizers. Moreover, these devices are used in non-respiratory diseases such as diabetes, analgesia, and Parkinson’s disease.

Aerosol-Delivery-Devices-Market-2020-2027

Get more information on this report : Request Sample Pages

 

Increase in prevalence of respiratory diseases such as COPD asthma and cystic fibrosis; surge in focus of manufacturers toward development of portable inhalation devices; increase in need for rescue medication treatment during sudden asthmatic attack; rise in demand for short-term, effective medication for asthma, and COPD; and government initiatives toward spread in awareness for COPD and asthma symptoms are the major factors that drive growth of the aerosol delivery devices market. In addition, rise in geriatric population, technological advancements in inhaler devices, rise in adoption of aerosol delivery devices by patients, rise in urbanization and pollution levels, and increase in number of R&D activities to develop ideal inhalation therapy are some other factors that contribute toward growth of the market. However, complications and side-effects associated with drug inhalation and high cost associated with nebulizers are expected to hinder growth of the market.

The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. According to a paper published by the Journal of Allergy and Clinical Immunology (JACI), in 2020, asthma and COPD patients appear to have increased their adherence to inhalation medications during the COVID-19. Moreover, some parts of developed countries such as the U.S. and the UK are experiencing shortages of bronchodilator inhalers such as albuterol inhalers, as hospitals are utilizing them for COVID-19 patients. Furthermore, according to data provided by the National Health Service (NHS) in 2020, number of salbutamol inhalers prescribed by general practitioners (GP) in England raised by 63% between February 2020 and March 2020. Thus, COVID-19 infection uplifted growth and opportunities for manufacturers of aerosol delivery devices during the forecast period.

Aerosol Delivery Devices Market Segmentation  

The global aerosol delivery devices market is segmented into product, application, and distribution channel. By product, the market is categorized into dry powder inhalers, metered dose inhalers, and nebulizers. The dry powder inhalers segment is further bifurcated into single dose inhalers and multi dose inhalers. The metered dose inhalers segment is further divided into conventional pressurized inhalers and soft mist inhalers. The nebulizers segment is further categorized into jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. On the basis of application, the market is segregated into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and non-respiratory diseases. The non-respiratory diseases segment is further divided is into diabetes, analgesia, and Parkinson’s disease. Depending on distribution channel, the market is classified into retail pharmacies, hospital pharmacies, and e-commerce. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Aerosol Delivery Devices Market
By Product

Your browser does not support the canvas element.

Metered Dose Inhaler segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Segment review 

Presently, on the basis of product, the metered dose inhaler segment is the major revenue contributor, and is projected to grow significantly during the forecast period. Rise in prevalence of respiratory diseases such as asthma, COPD, cystic fibrosis, and other respiratory diseases, increase in demand for metered dose inhalers, surge in patient awareness toward effective & advanced respiratory devices, and technological advancements by respiratory device manufacturers in MDIs are the key factors that boost growth of the segment.

Depending on application, the asthma segment is the major shareholder in the global aerosol delivery devices market, owing to rise in patient awareness toward lung diseases, surge in demand for metered dose inhalers (MDIs), rise in smoking population, increase in air pollution, and surge in geriatric population facing chronic respiratory problems, and increase in prevalence of asthma globally.

Aerosol Delivery Devices Market
By Distribution Channel

Your browser does not support the canvas element.

Retail Pharmacies segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Snapshot of Asia-Pacific aerosol delivery devices market  

Asia-Pacific presents lucrative opportunities for key players operating in the aerosol delivery devices market, owing to large population base susceptible to asthma and COPD, increase in public awareness toward use and benefits of these devices and affordability of medical devices, development of the R&D sector; rise in healthcare reforms; and technological advancements in aerosol delivery devices products. Moreover, rise in demand for inhalers and nebulizers, and increase in demand for home healthcare devices contribute toward growth of the market. Moreover, surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high aerosol delivery devices market share is expected to drive growth of the aerosol delivery devices market in the region.

The key players profiled in this report include 3M Company, Aerogen, Inc., Glaxosmithkline Plc (GSK), Johnson & Johnson (Actelion Pharmaceuticals Ltd), Koninklijke Philips N.V., Merck & Co., Inc., Metall Zug Group (Clement Clarke International Ltd), Recipharm AB (Bespak), Teva Pharmaceutical Industries Limited, Vectura Group PLC, Gerresheimer AG, Heitkamp & Thumann KG (H&T Presspart), Iconovo AB, Merxin Ltd, and Nemera.

Aerosol Delivery Devices Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 6.4% during 2019-2026.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the aerosol delivery devices market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers aerosol delivery devices market analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the aerosol delivery devices market.
  • A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global aerosol delivery devices market growth.

Key Market Segments

By Product

  • Dry powder inhalers
    • Single dose inhalers
    • Multi dose inhalers
  • Metered dose inhalers
    • Conventional pressurized inhalers,
    • Soft mist inhalers
  • Nebulizers
    • Jet nebulizers
    • Ultrasonic wave nebulizers
    • Vibrating mesh nebulizers

By Application

  • Asthma
  • Chronic obstructive pulmonary disease
  • Cystic fibrosis
  • Non respiratory diseases
    • Diabetes
    • Analgesia
    • Parkinson’s disease

By Distribution Channel

  • Retail pharmacies
  • Hospital pharmacies
  • E-commerce 

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China 
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Top player positioning, 2019
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in air pollution
3.5.1.2.Advantages over conventional drug delivery devices
3.5.1.3.Increase in prevalence of COPD and asthma
3.5.1.4.Rise in government initiatives

3.5.2.Restraint

3.5.2.1.High cost of asthma and COPD treatments
3.5.2.2.Lack of access  in underdeveloped countries

3.5.3.Opportunity

3.5.3.1.Growth opportunities in emerging markets

3.5.4.Impact analysis

3.6.Pricing analysis of aerosol delivery devices
3.7.Covid-19 Impact analysis on aerosol delivery devices market
3.8.Top manufacturers list by region
3.9.Product pipeline analysis
3.10.License terms information
3.11.Qualitative information on mass median aerodynamic diameter (MMAD)
3.12.Regulatory Information for U.S., Europe, Japan, and China: aerosol delivery sevices
3.13.Innovations in aerosol delivery devices market

CHAPTER 4:AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Dry powder inhalers (DPIs)

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type
4.2.5.Single dose inhalers

4.2.5.1.Market size and forecast

4.2.6.Multi dose inhalers

4.2.6.1.Market size and forecast

4.2.7.Market size and forecast, by application

4.3.Metered dose inhalers (MDIs)

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type
4.3.5.Conventional pressurized inhalers

4.3.5.1.Market size and forecast

4.3.6.Soft mist inhalers

4.3.6.1.Market size and forecast

4.3.7.Market size and forecast, by application

4.4.Nebulizers

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.4.4.Market size and forecast, by type
4.4.5.Jet nebulizers

4.4.5.1.Market size and forecast

4.4.6.Ultrasonic wave nebulizers

4.4.6.1.Market size and forecast

4.4.7.Vibrating mesh nebulizers

4.4.7.1.Market size and forecast

4.4.8.Market size and forecast, by application

CHAPTER 5:AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Asthma

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Chronic obstructive pulmonary disease (COPD)

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Cystic fibrosis

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Non-respiratory diseases

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.5.3.Market size and forecast, by type
5.5.4.Diabetes

5.5.4.1.Market size and forecast

5.5.5.Analgesia

5.5.5.1.Market size and forecast

5.5.6.Parkinson's disease

5.5.6.1.Market size and forecast

CHAPTER 6:AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL

6.1.Overview

6.1.1.Market size and forecast

6.2.Retail pharmacies

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Hospital pharmacies

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.E-commerce

6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country

CHAPTER 7:AEROSOL DELIVERY DEVICES MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. aerosol delivery devices market, by product
7.2.2.1.2.U.S. aerosol delivery devices market, by application
7.2.2.1.3.U.S. aerosol delivery devices market, by distribution channel

7.2.2.2.Canada

7.2.2.2.1.Canada aerosol delivery devices market, by product
7.2.2.2.2.Canada aerosol delivery devices market, by application
7.2.2.2.3.Canada aerosol delivery devices market, by distribution channel

7.2.2.3.Mexico

7.2.2.3.1.Mexico aerosol delivery devices market, by product
7.2.2.3.2.Mexico aerosol delivery devices market, by application
7.2.2.3.3.Mexico aerosol delivery devices market, by distribution channel

7.2.3.North America market size and forecast, by product
7.2.4.North America market size and forecast, by application
7.2.5.North America market size and forecast, by distribution channel

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany aerosol delivery devices market, by product
7.3.2.1.2.Germany aerosol delivery devices market, by application
7.3.2.1.3.Germany aerosol delivery devices market, by distribution channel

7.3.2.2.France

7.3.2.2.1.France aerosol delivery devices market, by product
7.3.2.2.2.France aerosol delivery devices market, by application
7.3.2.2.3.France aerosol delivery devices market, by distribution channel

7.3.2.3.UK

7.3.2.3.1.UK aerosol delivery devices market, by product
7.3.2.3.2.UK aerosol delivery devices market, by application
7.3.2.3.3.UK aerosol delivery devices market, by distribution channel

7.3.2.4.Italy

7.3.2.4.1.Italy aerosol delivery devices market, by product
7.3.2.4.2.Italy aerosol delivery devices market, by application
7.3.2.4.3.Italy aerosol delivery devices market, by distribution channel

7.3.2.5.Spain

7.3.2.5.1.Spain aerosol delivery devices market, by product
7.3.2.5.2.Spain aerosol delivery devices market, by application
7.3.2.5.3.Spain aerosol delivery devices market, by distribution channel

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe aerosol delivery devices market, by product
7.3.2.6.2.Rest of Europe aerosol delivery devices market, by application
7.3.2.6.3.Rest of Europe aerosol delivery devices market, by distribution channel

7.3.3.Europe market size and forecast, by product
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by distribution channel

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Japan

7.4.2.1.1.Japan aerosol delivery devices market, by product
7.4.2.1.2.Japan aerosol delivery devices market, by application
7.4.2.1.3.Japan aerosol delivery devices market, by distribution channel

7.4.2.2.China

7.4.2.2.1.China aerosol delivery devices market, by product
7.4.2.2.2.China aerosol delivery devices market, by application
7.4.2.2.3.China aerosol delivery devices market, by distribution channel

7.4.2.3.Australia

7.4.2.3.1.Australia aerosol delivery devices market, by product
7.4.2.3.2.Australia aerosol delivery devices market, by application
7.4.2.3.3.Australia aerosol delivery devices market, by distribution channel

7.4.2.4.India

7.4.2.4.1.India aerosol delivery devices market, by product
7.4.2.4.2.India aerosol delivery devices market, by application
7.4.2.4.3.India aerosol delivery devices market, by distribution channel

7.4.2.5.South Korea

7.4.2.5.1.South Korea aerosol delivery devices market, by product
7.4.2.5.2.South Korea aerosol delivery devices market, by application
7.4.2.5.3.South Korea aerosol delivery devices market, by distribution channel

7.4.2.6.Rest of Asia-Pacific

7.4.2.6.1.Rest of Asia-Pacific aerosol delivery devices market, by product
7.4.2.6.2.Rest of Asia-Pacific aerosol delivery devices market, by application
7.4.2.6.3.Rest of Asia-Pacific aerosol delivery devices market, by distribution channel

7.4.3.Asia-Pacific market size and forecast, by product
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by distribution channel

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil aerosol delivery devices market, by product
7.5.2.1.2.Brazil aerosol delivery devices market, by application
7.5.2.1.3.Brazil aerosol delivery devices market, by distribution channel

7.5.2.2.Saudi Arabia

7.5.2.2.1.Saudi Arabia aerosol delivery devices market, by product
7.5.2.2.2.Saudi Arabia aerosol delivery devices market, by application
7.5.2.2.3.Saudi Arabia aerosol delivery devices market, by distribution channel

7.5.2.3.South Africa

7.5.2.3.1.South Africa aerosol delivery devices market, by product
7.5.2.3.2.South Africa aerosol delivery devices market, by application
7.5.2.3.3.South Africa aerosol delivery devices market, by distribution channel

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA aerosol delivery devices market, by product
7.5.2.4.2.Rest of LAMEA aerosol delivery devices market, by application
7.5.2.4.3.Rest of LAMEA aerosol delivery devices market, by distribution channel

7.5.3.LAMEA market size and forecast, by product
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by distribution channel

CHAPTER 8:COMPANY PROFILES

8.1.3M COMPANY

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance

8.2.AEROGEN, INC.

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio

8.3.GLAXOSMITHKLINE PLC (GSK)

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance

8.4.JOHNSON & JOHNSON (ACTELION PHARMACEUTICALS LTD)

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments

8.5.KONINKLIJKE PHILIPS N.V.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments

8.6.MERCK & CO., INC.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance

8.7.METALL ZUG GROUP (CLEMENT CLARKE INTERNATIONAL LTD)

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance

8.8.RECIPHARM AB (BESPAK)

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.TEVA PHARMACEUTICAL INDUSTRIES LIMITED

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments

8.10.VECTURA GROUP PLC

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments

CHAPTER 9:APPLICATION BASED COMPANY PROFILES

9.1.GERRESHEIMER AG

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance

9.2.HEITKAMP & THUMANN KG (H&T PRESSPART)

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio

9.3.ICONOVO AB

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Key strategic moves and developments

9.4.MERXIN LTD

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio

9.5.NEMERA

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio

LIST OF TABLES

TABLE 01.AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 02.DRY POWDER INHALERS AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 03.DRY POWDER INHALERS AEROSOL DELIVERY DEVICES MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 04.DRY POWDER INHALERS AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 05.METERED DOSE INHALERS AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06.METERED DOSE INHALERS AEROSOL DELIVERY DEVICES MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 07.METERED DOSE INHALERS AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 08.NEBULIZERS AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.NEBULIZERS AEROSOL DELIVERY DEVICES MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 10.NEBULIZERS AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 11.AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 12.ASTHMA AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 13.CHRONIC OBSTRUCTIVE PULMONARY DISEASE AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 14.CYSTIC FIBROSIS AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 15.NON-RESPIRATORY DISEASES AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 16.NON-RESPIRATORY DISEASES AEROSOL DELIVERY DEVICES MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 17.AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 18.RETAIL PHARMACIES AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 19.HOSPITAL PHARMACIES AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 20.E-COMMERCE AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 21.AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 22.NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 23.U.S. AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 24.U.S. AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 25.U.S. AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 26.CANADA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 27.CANADA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 28.CANADA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 29.MEXICO AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 30.MEXICO AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 31.MEXICO AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 32.NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 33.NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 34.NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 35.EUROPE AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 36.GERMANY AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 37.GERMANY AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 38.GERMANY AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 39.FRANCE AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 40.FRANCE AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 41.FRANCE AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 42.UK AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 43.UK AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 44.UK AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 45.ITALY AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 46.ITALY AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 47.ITALY AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 48.SPAIN AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 49.SPAIN AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 50.SPAIN AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 51.REST OF EUROPE AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 52.REST OF EUROPE AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 53.REST OF EUROPE AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 54.EUROPE AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 55.EUROPE AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 56.EUROPE AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 57.ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 58.JAPAN AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 59.JAPAN AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 60.JAPAN AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 61.CHINA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 62.CHINA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 63.CHINA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 64.AUSTRALIA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 65.AUSTRALIA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 66.AUSTRALIA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 67.INDIA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 68.INDIA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 69.INDIA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 70.SOUTH KOREA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 71.SOUTH KOREA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 72.SOUTH KOREA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 73.REST OF ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 74.REST OF ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 75.REST OF ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 76.ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 77.ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 78.ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 79.LAMEA AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 80.BRAZIL AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 81.BRAZIL AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 82.BRAZIL AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 83.SAUDI ARABIA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 84.SAUDI ARABIA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 85.SAUDI ARABIA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 86.SOUTH AFRICA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 87.SOUTH AFRICA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 88.SOUTH AFRICA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 89.REST OF LAMEA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 90.REST OF LAMEA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 91.REST OF LAMEA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 92.LAMEA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 93.LAMEA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 94.LAMEA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 95.3M: COMPANY SNAPSHOT
TABLE 96.3M: OPERATING SEGMENTS
TABLE 97.3M: PRODUCT PORTFOLIO
TABLE 98.AEROGEN: COMPANY SNAPSHOT
TABLE 99.AEROGEN: PRODUCT PORTFOLIO
TABLE 100.GSK: COMPANY SNAPSHOT
TABLE 101.GLAXOSMITHKLINE PLC: OERATING SEGMENT
TABLE 102.GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
TABLE 103.J&J: COMPANY SNAPSHOT
TABLE 104.J&J: OPERATING SEGMENTS
TABLE 105.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 106.J&J: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107.PHILIPS: COMPANY SNAPSHOT
TABLE 108.PHILIPS: OERATING SEGMENT
TABLE 109.PHILIPS: PRODUCT PORTFOLIO
TABLE 110.PHILIPS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 111.MERCK & CO., INC.: COMPANY SNAPSHOT
TABLE 112.MERCK & CO., INC.: OPERATING SEGMENTS
TABLE 113.MERCK & CO., INC.: PRODUCT PORTFOLIO
TABLE 114.METALL ZUG: COMPANY SNAPSHOT
TABLE 115.METALL ZUG: OERATING SEGMENT
TABLE 116.METALL ZUG: PRODUCT PORTFOLIO
TABLE 117.RECIPHARM: COMPANY SNAPSHOT
TABLE 118.RECIPHARM: OERATING SEGMENT
TABLE 119.RECIPHARM: PRODUCT PORTFOLIO
TABLE 120.RECIPHARM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 121.TEVA: COMPANY SNAPSHOT
TABLE 122.TEVA: PRODUCT PORTFOLIO
TABLE 123.TEVA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124.VECTURA: COMPANY SNAPSHOT
TABLE 125.VECTURA: PRODUCT PORTFOLIO
TABLE 126.VECTURA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127.GERRESHEIMER: COMPANY SNAPSHOT
TABLE 128.GERRESHEIMER: OERATING SEGMENT
TABLE 129.GERRESHEIMER: PRODUCT PORTFOLIO
TABLE 130.HEITKAMP & THUMANN: COMPANY SNAPSHOT
TABLE 131.HEITKAMP & THUMANN: OERATING SEGMENT
TABLE 132.HEITKAMP & THUMANN.: PRODUCT PORTFOLIO
TABLE 133.ICONOVO: COMPANY SNAPSHOT
TABLE 134.ICONOVO: PRODUCT PORTFOLIO
TABLE 135.ICONOVO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 136.MERXIN: COMPANY SNAPSHOT
TABLE 137.MERXIN.: PRODUCT PORTFOLIO
TABLE 138.NEMARA: COMPANY SNAPSHOT
TABLE 139.NEMARA.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.GLOBAL AEROSOL DELIVERY DEVICES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2019
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2019
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017–2019
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2019
FIGURE 12.IMPACT ANALYSIS:
FIGURE 13.COMPARATIVE ANALYSIS OF DRY POWDER INHALERS AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 14.SINGLE DOSE INHALERS MARKET, 2019–2027, ($MILLION)
FIGURE 15.MULTI DOSE INHALERS MARKET, 2019–2027, ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF METERED DOSE INHALERS AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 17.CONVENTIONAL PRESSURIZED INHALERS MARKET, 2019–2027, ($MILLION)
FIGURE 18.SOFT MIST INHALERS MARKET, 2019–2027, ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF NEBULIZERS AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 20.JET NEBULIZERS MARKET, 2019–2027, ($MILLION)
FIGURE 21.ULTRASONIC WAVE NEBULIZERS MARKET, 2019–2027, ($MILLION)
FIGURE 22.VIBRATING MESH NEBULIZERS MARKET, 2019–2027, ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF ASTHMA AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 25.COMPARATIVE ANALYSIS OF CYSTIC FIBROSIS AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 26.COMPARATIVE ANALYSIS OF NON-RESPIRATORY DISEASES AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 27.DIABETES MARKET, 2019–2027, ($MILLION)
FIGURE 28.ANALGESIA MARKET, 2019–2027, ($MILLION)
FIGURE 29.PARKINSON'S DISEASE MARKET, 2019–2027, ($MILLION)
FIGURE 30.COMPARATIVE ANALYSIS OF RETAIL PHARMACIES AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 31.COMPARATIVE ANALYSIS OF HOSPITAL PHARMACIES AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 32.COMPARATIVE ANALYSIS OF E-COMMERCE AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 33.3M: NET SALES, 2017–2019 ($MILLION)
FIGURE 34.3M: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 35.3M: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 36.GSK: TURNOVER:, 2017–2019 ($MILLION)
FIGURE 37.GSK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 38.GSK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 39.J&J: NET SALES, 2017–2019 ($MILLION)
FIGURE 40.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 41.J&J: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 42.PHILIPS: NET SALES, 2017–2019 ($MILLION)
FIGURE 43.PHILIPS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 44.PHILIPS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 45.MERCK & CO., INC.: NET SALES, 2017–2019 ($MILLION)
FIGURE 46.MERCK & CO., INC.: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 47.MERCK & CO., INC.: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 48.METALL ZUG: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.METALL ZUG: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 50.METALL ZUG: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.RECIPHARM: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.RECIPHARM: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 53.RECIPHARM: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 54.TEVA: NET SALES, 2017–2019 ($MILLION)
FIGURE 55.VECTURA: NET SALES, 2017–2019 ($MILLION)
FIGURE 56.VECTURA: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 57.GERRESHEIMER: NET SALES, 2017–2019 ($MILLION)
FIGURE 58.GERRESHEIMER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 59.GERRESHEIMER: REVENUE SHARE, BY REGION, 2019 (%)

 
 

Aerosol delivery devices are used to deliver medicines to lungs and airways. These devices are mainly used to treat or prevent diseases of airways such as asthma, chronic obstructive pulmonary disease (COPD) or cystic fibrosis. Moreover, they are used to treat non respiratory diseases such as diabetes, analgesia, thyroid disorder, and others.

Increase in patient awareness toward inhalation therapies, increase in prevalence of asthma and COPD, technological advancements in inhaler devices, rise in demand for MDI & DPI, and rise in geriatric population are expected to drive growth of the aerosol delivery devices market. Furthermore, introduction of novel & advanced aerosol delivery devices propel the market growth. However, complications and side-effects associated with drug inhalation and higher cost of these devices hinder the growth of the market.  

North America is expected to remain dominant during the forecast period, owing to increase in demand for aerosol delivery devices, rise in prevalence of chronic respiratory diseases, and presence of major key players along with R&D centers. Moreover, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to key players during the forecast period, owing to increase in patient awareness toward aerosol drug delivery treatment.


 

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
 

A. The total market value of Aerosol Delivery Devices market is $31,463.9 million in 2019.

A. The forcast period for Aerosol Delivery Devices market is 2020 to 2027

A. The market value of Aerosol Delivery Devices market in 2020 is $33,411.6 million.

A. The base year is 2019 in Aerosol Delivery Devices market

A. Top companies such as Glaxosmithkline Plc (GSK), Merck & co., Inc., Vectura Group Plc, Koninklijke Philips N.V., 3M Company, Teva Pharmaceutical Industries Limited, and Aerogen, Inc. held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Metered dose inhalers segment is the most influencing segment owing to rise in prevalence of respiratory diseases such as asthma, COPD, cystic fibrosis, and other respiratory diseases, increase in demand for metered dose inhalers, surge in patient awareness toward effective & advanced respiratory devices, and technological advancements by respiratory device manufacturers in MDIs

A. The major factor that fuels the growth of the global Aerosol Delivery Devices market includes rise in prevalence of asthma, COPD, and other respiratory disorders, increase in smoking population, ease of administration of drug with aerosol delivery devices, rise in demand for metered-dose inhalers, technological advancements in inhaler devices, and rise in geriatric population, rise in adoption of aerosol delivery devices by patients, and increase in patient awareness toward inhalation therapy,

A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as India with a CAGR of 7.1%. This is due to increase in prevalence of asthma, COPD and chronic respiratory diseases, improvement in healthcare facilities, increase in public awareness toward the use and benefits of these devices and affordability of medical devices.

A. Aerosol delivery devices are generally used as facilitators to provide drugs to patients. Inhaled medication through lungs is mostly provided to prevent or relieve asthma, COPD and other respiratory & non-respiratory ailments

A. Aerosol Delivery Devices products are used for direct deposition of inhaled medication to airway receptor sites

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Aerosol Delivery Devices Market

  • Online Only
  • $4,099
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,555
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $7,651
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,670
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts